---
figid: PMC6109055__41467_2018_5966_Fig6_HTML
figlink: /pmc/articles/PMC6109055/figure/Fig6/
number: Fig. 6
caption: 'Model: SIRT6 levels regulate resistance or sensitivity to MAPKi. (Top) Under
  baseline conditions, SIRT6 deacetylates H3K56ac at the IGFBP2 locus to maintain
  low expression levels and low IGF-1R/AKT pathway signaling, impairing cell survival
  in the presence of MAPKi. (Middle) In the context of SIRT6 haploinsufficiency, IGFBP2
  expression is enhanced via increased chromatin accessibility and H3K56 acetylation
  at the IGFBP2 locus. Activation of the IGF-1 receptor (IGF-1R) and downstream AKT
  signaling allows melanoma cells to persist in the presence of MAPKi. (Bottom) SIRT6
  depletion triggers significant chromatin reorganization reflected by increased open
  chromatin and H3K56ac at these sites, coupled to DNA damage accumulation. This potential
  for genomic instability increases the sensitivity to MAPKi'
pmcid: PMC6109055
papertitle: SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to
  MAPK inhibitors via IGF signalling.
reftext: Thomas Strub, et al. Nat Commun. 2018;9:3440.
pmc_ranked_result_index: '39949'
pathway_score: 0.8329722
filename: 41467_2018_5966_Fig6_HTML.jpg
figtitle: 'Model: SIRT6 levels regulate resistance or sensitivity to MAPKi'
year: '2018'
organisms: Homo sapiens
ndex: af8ab63b-de98-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6109055__41467_2018_5966_Fig6_HTML.html
  '@type': Dataset
  description: 'Model: SIRT6 levels regulate resistance or sensitivity to MAPKi. (Top)
    Under baseline conditions, SIRT6 deacetylates H3K56ac at the IGFBP2 locus to maintain
    low expression levels and low IGF-1R/AKT pathway signaling, impairing cell survival
    in the presence of MAPKi. (Middle) In the context of SIRT6 haploinsufficiency,
    IGFBP2 expression is enhanced via increased chromatin accessibility and H3K56
    acetylation at the IGFBP2 locus. Activation of the IGF-1 receptor (IGF-1R) and
    downstream AKT signaling allows melanoma cells to persist in the presence of MAPKi.
    (Bottom) SIRT6 depletion triggers significant chromatin reorganization reflected
    by increased open chromatin and H3K56ac at these sites, coupled to DNA damage
    accumulation. This potential for genomic instability increases the sensitivity
    to MAPKi'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT2
  - ADCY4
  - ADCY10
  - AKT3
  - IGF1R
  - TF
  - MAPK10
  - MAPK13
  - SIRT6
  - ADCY9
  - ADCY1
  - IGFBP2
  - MAPK12
  - ADCY6
  - ADCY8
  - MAPK9
  - MAPK3
  - ADCY3
  - MAPK14
  - MAPK1
  - ADCY2
  - ADCY7
  - MAPK11
  - ADCY5
  - MAPK8
  - Ac
  - linsitinib
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: TF
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: SIRT6
  symbol: SIRT6
  source: hgnc_symbol
  hgnc_symbol: SIRT6
  entrez: '51548'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: IGFBP2
  symbol: IGFBP2
  source: hgnc_symbol
  hgnc_symbol: IGFBP2
  entrez: '3485'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
chemicals:
- word: Ac
  source: MESH
  identifier: D000186
- word: linsitinib
  source: MESH
  identifier: C551528
diseases: []
---
